Minimal residual disease detection after allogeneic stem cell transplantation is correlated to relapse in patients with acute lymphoblastic leukaemia

scientific article published in September 2003

Minimal residual disease detection after allogeneic stem cell transplantation is correlated to relapse in patients with acute lymphoblastic leukaemia is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1046/J.1365-2141.2003.04495.X
P698PubMed publication ID12930390
P5875ResearchGate publication ID10604837

P50authorJonas MattssonQ44779136
P2093author name stringOlle Ringdén
Mehmet Uzunel
Marie Jaksch
P2860cites workPrimers and protocols for standardized detection of minimal residual disease in acute lymphoblastic leukemia using immunoglobulin and T cell receptor gene rearrangements and TAL1 deletions as PCR targets: report of the BIOMED-1 CONCERTED ACTION: invQ38328321
Minimal residual disease (MRD) status prior to allogeneic stem cell transplantation is a powerful predictor for post-transplant outcome in children with ALL.Q38455373
Prognostic value of minimal residual disease in acute lymphoblastic leukaemia in childhood.Q53349829
P433issue5
P407language of work or nameEnglishQ1860
P921main subjectleukemiaQ29496
P304page(s)788-794
P577publication date2003-09-01
P1433published inBritish Journal of HaematologyQ4970200
P1476titleMinimal residual disease detection after allogeneic stem cell transplantation is correlated to relapse in patients with acute lymphoblastic leukaemia
P478volume122

Reverse relations

cites work (P2860)
Q36997720Allogeneic transplantation for childhood ALL.
Q37227738Automated detection of residual cells after sex-mismatched stem-cell transplantation - evidence for presence of disease-marker negative residual cells
Q81306380B-cell reconstitution after allogeneic SCT impairs minimal residual disease monitoring in children with ALL
Q38105123Clinical significance of minimal residual disease in patients with acute leukaemia undergoing haematopoietic stem cell transplantation
Q47209362Follow-up of post-transplant minimal residual disease and chimerism in childhood lymphoblastic leukaemia: 90 d to react.
Q52632345Hematopoietic Stem Cell Transplantation for Adult Philadelphia-Negative Acute Lymphoblastic Leukemia in the First Complete Remission in the Era of Minimal Residual Disease.
Q48109702Hematopoietic Stem Cell Transplantation for Childhood Acute Lymphoblastic Leukemia and the Role of MRD: A Single Centre Experience from India
Q37601706Immunoglobulin and T cell receptor gene high-throughput sequencing quantifies minimal residual disease in acute lymphoblastic leukemia and predicts post-transplantation relapse and survival
Q48028225Immunoglobulin and T-cell receptor gene rearrangements as PCR-based targets are stable markers for monitoring minimal residual disease in acute lymphoblastic leukemia after stem cell transplantation
Q38681322Impact of minimal residual disease, detected by flow cytometry, on outcome of myeloablative hematopoietic cell transplantation for acute lymphoblastic leukemia
Q36726108Methods of minimal residual disease (MRD) detection in childhood haematological malignancies
Q43014298NCI First International Workshop on the Biology, Prevention, and Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation: report from the Committee on Disease-Specific Methods and Strategies for Monitoring Relapse following All
Q39106254Overexpression of miR-708 and its targets in the childhood common precursor B-cell ALL.
Q49894494Photochemotherapy and Graft-versus-Leukemia Reaction in Acute Leukemia: Tumor Immunity and Survival Are Dependent on Timing of Photochemotherapy of the Skin
Q35100974Prophylaxis and treatment of acute lymphoblastic leukemia relapse after allogeneic hematopoietic stem cell transplantation
Q37628681Recent advances in quantitative chimerism analysis
Q33886177Relationship between minimal residual disease measured by multiparametric flow cytometry prior to allogeneic hematopoietic stem cell transplantation and outcome in children with acute lymphoblastic leukemia.
Q41844565Single nucleotide polymorphism-based system improves the applicability of quantitative PCR for chimerism monitoring
Q41688221The effect of peritransplant minimal residual disease in adults with acute lymphoblastic leukemia undergoing allogeneic hematopoietic stem cell transplantation
Q54627391Wilms' tumor gene 1 (WT1) expression in childhood acute lymphoblastic leukemia: a wide range of WT1 expression levels, its impact on prognosis and minimal residual disease monitoring.

Search more.